Trxade Group (NASDAQ: MEDS) and its wholly owned
subsidiary, Integra Pharma Solutions, were recently featured in a CoStar.com article
titled ‘Lee & Associates Atlanta to Reopen Office Monday, Offer Coronavirus
Antibody Testing’. The article reports that commercial property firm Lee &
Associates Atlanta will be one of the first Atlanta-based firms to reopen. The
firm is working with Saidcard and Integra Pharma Solutions to ensure its
employees will be tested for the COVID-19 antibodies. These antibodies “show if
you had a previous infection with the virus,” according to the Centers for
Disease Control and Prevention (“CDC”). The CDC also stated that it is unclear
if the antibodies provide immunity from getting infected again. “We are working
to ensure that all of the test kits we are providing our customers through
Integra Pharma are sourced from manufacturers that have submitted an emergency
use authorization with the [Food & Drug Administration],” Saidcard Chief
Operating Officer Jo Ram said in a statement. “Additionally, as we roll this
offering out to our customers, if a person tests positive for antibodies, we
follow it up with a PCR test to see if they currently have the virus and need
to be quarantined, or are virus free and can go back to work.”
To view the full article, visit http://ibn.fm/VoD6G
About Trxade Group Inc.
Headquartered in Tampa, Florida, Trxade Group is an
integrated drug-procurement, delivery and healthcare platform that enables
price transparency and increased profit margins to buyers and sellers of
pharmaceuticals, makes healthcare services affordable and accessible across all
50 states, and steps in to meet today’s immediate demands. Founded in 2010,
Trxade Group is comprised of four synergistic operating platforms: the Trxade
B2B trading platform with 12,100 registered pharmacies, a licensed virtual
wholesaler, affordable healthcare via its Bonum Health app or web-based
telehealth services, and same-day or mail-order pharmacy-delivery capabilities
via its DelivMeds app featuring its extensive nationwide distribution network.
For additional information, please visit www.Trxade.com.
NOTE TO INVESTORS: The latest news and updates
relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
